Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VPTDF - Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting


VPTDF - Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

(TheNewswire)



Toronto, Ontario – TheNewswire –December 15, 2020 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ; ( OTC:VPTDF) held its Annual General & Special Shareholdersmeeting via conference call yesterday, December 14, 2020.

All resolutions considered and voted upon byshareholders were approved by a greater than 95% majority ofshareholder votes.

All Board of Directors nominees were elected withgreater than 99% majority of the shareholder votes.

The Shareholders approved an amendment to theCompany’s articles to change the province in which the Company’sregistration is located from Alberta to Ontario.

The CEO slide presentation is available on theVentripoint website at: https://179b49c1-1e6c-43e8-8e81-82a04e05b727.filesusr.com/ugd/8e5203_3c104b726d68413f9f55383b6fe60978.pdf .

In addition, A CEO video presentation can be viewed at: https://ca.proactiveinvestors.com/companies/news/936483/ventripoint-diagnostics-recent-grants-gives-company-runway-to-execute-on-sales-plans-in-2021-936483.html

About Ventripoint DiagnosticsLtd.

Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada.

For further information, pleasecontact:

Dr. George Adams

Email :gadams@ventripoint.com

Phone: 519-803-6937 ????????

Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.

Forward Looking Statements

This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Company.Although the Company believes that the expectations and assumptions onwhich such forward-looking statements and information are based arereasonable, undue reliance should not be placed on the forward-lookingstatements and information because the Company can give no assurancethat they will prove to be correct.

Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Company's mostrecent annual management's discussion and analysis that is availableon the Company's profile on SEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Company undertakes no obligation to update publicly orrevise any forward-looking statements or information, whether as aresult of new information, future events or otherwise, unless sorequired by applicable securities laws.

Copyright (c) 2020 TheNewswire - All rights reserved.

Stock Information

Company Name: VentriPoint Diagnostics Ltd
Stock Symbol: VPTDF
Market: OTC
Website: ventripoint.com

Menu

VPTDF VPTDF Quote VPTDF Short VPTDF News VPTDF Articles VPTDF Message Board
Get VPTDF Alerts

News, Short Squeeze, Breakout and More Instantly...